ArticlePDF Available

Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive

Authors:
  • Children's Health Ireland at Crumlin
  • Health Policy Analysis

Abstract

OBJECTIVE To determine the separate and combined effects of high-protein (HP) and high-fat (HF) meals, with the same carbohydrate content, on postprandial glycemia in children using intensive insulin therapy (IIT).RESEARCH DESIGN AND METHODS Thirty-three subjects aged 8-17 years were given 4 test breakfasts with the same carbohydrate amount but varying protein and fat quantities: low fat (LF)/low protein (LP), LF/HP, HF/LP, and HF/HP. LF and HF meals contained 4 g and 35 g fat. LP and HP meals contained 5 g and 40 g protein. An individually standardized insulin dose was given for each meal. Postprandial glycemia was assessed by 5 h continuous glucose monitoring.RESULTSCompared with the LF/LP meal, mean glucose excursions were greater from 180 min after the LF/HP meal (2.4 mmol/L [95% CI 1.1-3.7] vs. 0.5 mmol/L [-0.8 to 1.8]; P = 0.02) and from 210 min after the HF/LP meal (1.8 mmol/L [0.3-3.2] vs. -0.5 mmol/L [-1.9 to 0.8]; P = 0.01). The HF/HP meal resulted in higher glucose excursions from 180 min to 300 min (P < 0.04) compared with all other meals. There was a reduction in the risk of hypoglycemia after the HP meals (odds ratio 0.16 [95% CI 0.06-0.41]; P < 0.001).CONCLUSIONS Meals high in protein or fat increase glucose excursions in youth using IIT from 3 h to 5 h postmeal. Protein and fat have an additive impact on the delayed postprandial glycemic rise. Protein had a protective effect on the development of hypoglycemia.
Both Dietary Protein and Fat Increase
Postprandial Glucose Excursions
in Children With Type 1 Diabetes,
and the Effect Is Additive
CARMEL E.M. SMART,RD,PHD
1,2
MEGAN EVANS,RD, PGRADDIPDIET
3
SUSAN M. OCONNELL,MD,FRACP
3,4
PATRICK MCELDUFF,PHD
2
PRUDENCE E. LOPEZ,MD
2,5
TIMOTHY W. JONES,MD,FRACP
3,4,6
ELIZABETH A. DAVIS,MD,PHD
3,4,6
BRUCE R. KING,MD,PHD
1,5
OBJECTIVEdTo determine the separate and combined effects of high-protein (HP) and high-
fat (HF) meals, with the same carbohydrate content, on postprandial glycemia in children using
intensive insulin therapy (IIT).
RESEARCH DESIGN AND METHODSdThirty-three subjects aged 817 years were
given 4 test breakfasts with the same carbohydrate amount but varying protein and fat quantities:
low fat (LF)/low protein (LP), LF/HP, HF/LP, and HF/HP. LF and HF meals contained 4 g and 35 g
fat. LP and HP meals contained 5 g and 40 g protein. An individuallystandardized insulin dose was
given for each meal. Postprandial glycemia was assessed by 5-h continuous glucose monitoring.
RESULTSdCompared with the LF/LP meal, mean glucose excursions were greater from 180
min after the LF/HP meal (2.4 mmol/L [95% CI 1.13.7] vs. 0.5 mmol/L [20.8 to 1.8]; P=0.02)
and from 210 min after the HF/LP meal (1.8 mmol/L [0.33.2] vs. 20.5 mmol/L [21.9 to 0.8];
P= 0.01). The HF/HP meal resulted in higher glucose excursions from 180 min to 300 min (P,
0.04) compared with all other meals. There was a reduction in the risk of hypoglycemia after the
HP meals (odds ratio 0.16 [95% CI 0.060.41]; P,0.001).
CONCLUSIONSdMeals high in protein or fat increase glucose excursions in youth
using IIT from 3 h to 5 h postmeal. Protein and fat have an additive impact on the delayed
postprandial glycemic rise. Protein had a protective effect on the development of
hypoglycemia.
Diabetes Care 36:38973902, 2013
Current management of people with
type 1 diabetes (T1D) on intensive
insulin therapy (IIT) advocates al-
gorithms based on the carbohydrate con-
tent of the meal to calculate the prandial
insulin dose (1,2). This approach is recom-
mended as a means to improve glycemic
control and allow greater dietary exibility
(3,4). Typically, these calculations do not
take into account the protein and fat con-
tent of the meal.
In recent years, novel algorithms have
recommended counting fat and protein
units, in addition to carbohydrate, in
order to determine a supplementary
insulin requirement for high-fat and
-protein meals (5). However, increased
postprandial hypoglycemia has been
observed in children following these rec-
ommendations (6). A recent study (7)
showed that meals high in fat do require
more insulin than lower-fat meals with the
same carbohydrate content, supporting
the need for alternative insulin dosing al-
gorithms for high-fat (HF) meals. How-
ever, there is a general paucity of
evidence regarding the impact of protein
and fat on postprandial glycemia in pa-
tients utilizing IIT, and consistent clinical
advice for optimal management of high-
protein (HP) and HF meals is lacking.
To date, protein has been considered
together with fat in test meal studies, and
controlled trials examining the effect of
variations in protein content, indepen-
dent of other macronutrients, on post-
prandial glucose levels have not been
performed in individuals with T1D using
insulin pump or multiple daily injection
therapies. Therefore, this study was un-
dertaken to examine the separate and
combined effects of HP and HF meals,
all with the same carbohydrate content,
on postprandial glycemia in children and
adolescents using IIT.
RESEARCH DESIGN AND
METHODSdThe study design was a
four-by-four randomized crossover trial
conducted at two pediatric centers in
Australia (Princess Margaret Hospital in
Perth and John Hunter Childrens Hospital
in Newcastle). Children and adolescents
with T1D who had been diagnosed for
.1 year and who had been treated with
continuous subcutaneous insulin infusion
or multiple daily injection ($4 injections/
day) for .6 months were recruited. Inclu-
sion criteria included age between 8 and 17
years, glycated hemoglobin (HbA
1c
)
#8.0% (64 mmol/mol), and BMI #97th
percentile. Exclusion criteria were coexist-
ing medical problems (including celiac dis-
ease), evidence of complications of diabetes
(including gastroparesis), hyperlipidemia,
and dietary restrictions.
Ethics approval was obtained from
the ethics committees of the Princess
Margaret ChildrensHospitalandthe
ccccccccccccccccccccccccccccccccccccccccccccccccc
From the
1
Department of Paediatric Endocrinology and Diabetes, John Hunter Childrens Hospital, Newcastle,
New South Wales, Australia; the
2
Hunter Medical Research Institute, School of Medicine and Public Health,
University of Newcastle, Rankin Park, New South Wales, Australia; the
3
Department of Endocrinology and
Diabetes, Princess Margaret Hospital for Children, Perth, Western Australia, Australia; the
4
Telethon In-
stitute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth,
Western Australia, Australia; the
5
Faculty of Health, School of Medicine, University of Newcastle, New-
castle, New South Wales, Australia; and the
6
School of Paediatrics and Child Health, University of Western
Australia, Perth, Western Australia, Australia.
Corresponding author: Bruce R. King, bruce.king@hnehealth.nsw.gov.au.
Received 20 May 2013 and accepted 27 July 2013.
DOI: 10.2337/dc13-1195
A slide set summarizing this article is available online.
© 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educa tional and not for prot, and the work is not alte red. See http://creativecommons.org/
licenses/by-nc-nd/3.0/ for details.
care.diabetesjournals.org DIABETES CARE ,VOLUME 36, DECEMBER 2013 3897
Clinical Care/Education/Nutrition/Psychosocial Research
ORIGINAL ARTICLE
©
John Hunter Childrens Hospital. Written
informed consent was gained from all
participants and their parents.
In the week leading up to the study,
participants and their caregivers were
contacted daily by telephone to review
the subjects blood glucose level (BGL).
Adjustments were made, if required, to
the participants insulin therapy to
meet a prebreakfast target range of 48
mmol/L and to optimize each partici-
pants insulin-to-carbohydrate ratio. If
the subjects fasting glucose values were
high (.12.0 mmol/L) or low (,3.6
mmol/L), participants were instructed to
treat as normal, e.g., for hyperglycemia,
administer a correction bolus. This study
day was then excluded and repeated.
Participants received their breakfast
(test meal) under supervision by one of
the two study centers over four consecu-
tive mornings. Four standardized test
meals of high- or low-fat and high- or
low-protein content, all with the same
carbohydrate amount, were given under
supervision to each participant in random
order over the four study days. Children
were required to fast overnight for at least
10 h prior to breakfast, consume the test
meal in 20 min, and fast for 5 h after
completion of the test meal. Activity was
standardized (sedentary) during the 5-h
postprandial period for each participant.
The insulin dose for each participant
was determined for the carbohydrate
content using each participants individ-
ualized insulin-to-carbohydrate ratio.
This dose then remained constant for
each of the four test meals. The short-
acting insulin bolus was administered 10
min prior to test meal consumption via
subcutaneous injection or as a standard
bolus via the insulin pump. In the event
of hypoglycemia during the 5-h postpran-
dial period, 15 g oral carbohydrate was
given and analysis stopped at that point.
Participants using continuous subcutane-
ous insulin infusion changed their infu-
sion site on day 1 and day 3 of the study.
Test meals
Test meals consisted of pancakes varying
in protein and fat content but identical in
carbohydrate amount. The low-fat (LF)
and HF meals contained 4 g fat and 35 g
fat, respectively, and the low-protein (LP)
meal and HP meals contained 5 g protein
and 40 g protein, respectively. All meals
contained the same amount of carbohy-
drate (30 g, 120 kcal). The total energy
content of the four test meals was 180 kcal
for the LF/LP meal, 330 kcal for the LF/HP
meal, 460 kcal for the HF/LF meal, and
615 kcal for the HF/HP meal. Beneprotein
(100% whey protein isolate) was used to
increase the protein content of the meals
without impacting the fat and carbohy-
drate quantities. See Table 1 for a detailed
description of the meals.
The fat and protein amounts were
based on quantities in foods commonly
consumed by children and adolescents
with diabetes (8). A weight-based cut
point for protein was derived from rec-
ommendations of upper levels of protein
intakes for children (9). To ensure an ap-
propriate protein amount for children
#45 kg, 75% of the total serving for
each pancake was provided. The reduc-
tion in the serving size for the smaller chil-
dren resulted in all macronutrients being
altered proportionally to provide 75% of
the amount in the full serving. The meal
types were given to patients in a random
order, which was predetermined based
on a generalized cyclic block design and
was generated using Proc Plan in SAS
v9.3, 2010 (SAS Institute, Cary, NC).
Food was prepared under controlled con-
ditions and weighed using Salter kitchen
scales (accuracy 61 g, model 323; Salter,
Kent, U.K.).
Glucose measurement
The iPro2 Continuous Glucose Monitor-
ing System (CGMS; MedtronicMiniMed,
Northbridge, CA) was used to record glu-
cose levels in the participants over the 4
days of the study. Subjects attended the
clinic on the day prior to the study
Table 1dMacronutrient composition for LF, HF, LP, and HP test meals
Test meal and ingredients Carbohydrate (g) Fat (g) Protein (g) Fiber (g)
LF/LP
Wheat our 20.5 0.3 2.8 1.1
Full-cream milk 2.0 1.0 1.1 0.0
Eggs 0.0 1.1 1.4 0.0
Castor sugar 7.8 0.0 0.0 0.0
Sunower oil 0.0 1.6 0.0 0.0
Total 30.3 4.0 5.3 1.1
LF/HP
Wheat our 20.5 0.3 2.8 1.1
Evaporated skim milk 6.4 0.2 4.9 0.0
Skim milk powder 3.1 0.0 2.2 0.0
Eggs 0.0 1.1 1.4 0.0
Egg white 0.0 0.0 0.9 0.0
Sunower oil 0.0 2.3 0.0 0.0
Beneprotein 0.0 0.0 27.8 0.0
Total 30.0 3.9 40.0 1.1
HF/LP
Wheat our 20.5 0.3 2.8 1.1
Full-cream milk 2.0 1.0 1.1 0.0
Eggs 0.0 1.1 1.4 0.0
Castor sugar 7.8 0.0 0.0 0.0
Sunower oil 0.0 8.2 0.0 0.0
Double cream (50% fat) 0.0 20.3 0.0 0.0
Butter 0.0 4.1 0.0 0.0
Total 30.3 35.0 5.3 1.1
HF/HP
Wheat our 20.5 0.3 2.8 1.1
Evaporated full-fat milk 5.7 3.9 3.4 0.0
Full-cream milk powder 3.6 2.7 2.4 0.0
Eggs 0.0 1.7 2.1 0.0
Sunower oil 0.0 6.4 0.0 0.0
Double cream (50% fat) 0.0 12.4 0.4 0.0
Butter 0.0 7.8 0.0 0.0
Beneprotein 0.0 0.0 28.9 0.0
Total 29.8 35.2 40.0 1.1
Subjects #45 kg consumed 75% of the total serve for each test meal.
3898 DIABETES CARE,VOLUME 36, DE CEMBER 2013 care.diabetesjournals.org
Protein and fat impact postprandial glycemia
©
commencement for insertion of CGMS.
Participants were asked to record at least
four capillary blood glucose measure-
ments per day into their study diary to
allow for calibration. At the completion
ofthestudy,dataweredownloaded
from the CGMS using the Medtronic
CareLinkiPro data system (Medtronic
MiniMed).
Statistical analysis
The primary outcome measure was the
glucose excursion at each 30-min interval
from baseline to 300 min after each of the
four test meals. This was calculated as the
observed postprandial glucose level mi-
nus the subjects glucose level at baseline.
Secondary outcomes included hypogly-
cemic event (dened as a capillary BGL
,3.6 mmol/L), peak glucose excursion,
and time to peak glucose excursion. Glu-
cose excursion data for children who
had a hypoglycemic event were not in-
cluded after the time of the event.
Differences in mean glucose excur-
sions between meal groups at a single time
point were tested using a generalized
linear mixed model to account for the
repeated measurements on the same chil-
dren. The outcome in the model was
glucose excursion, and the only predictor
was meal type, which was included as a
four-level factor. A second set of models
was tted to examine the interaction
between the effect of fat and protein.
This set of models had predictors of fat,
protein, and the interaction of fat and
protein. Generalized linear mixed models
were also used to test for differences in
mean peak glucose excursions and mean
time to peak glucose excursions. Differences
between meal types in the proportion of
subjects who had a hypoglycemic event
were examined using a logistic regression
model within a generalized estimating
equation framework.
Pvalues ,0.05 were considered sta-
tistically signicant. Data analysis was
conducted using SAS (SAS Institute) and
Stata statistical software, 2011, release 12
(StataCorp 2011, College Station, TX).
RESULTSdThe mean (SD) age of the
33 children who completed the study was
12.2 (2.5) years, and 17 (52%) were
female. Other baseline characteristics are
presented in Table 2.
The prebreakfast target range of 48
mmol/L was achieved on 78 days over the
132 study days. Ninety-seven percent of
fasting glucose values (n= 128) were be-
tween 3.6 and 12.0 mmol/L, requiring 4
study days to be repeated because of high
or low fasting glucose values. On each oc-
casion, the day was successfully repeated.
Nine children had incomplete study
days where data from 1 day were ex-
cluded from the analysis due to an in-
complete sensor reading over the 5-h
postprandial period (n= 7) or failure to
complete one of the test meals in 20 min
(n= 2). Data from all of the other days (n=
123) were included in the analysis.
Twelve children weighed #45 kg and
were given 75% of the total meal serving.
The outcome data for these children did
not differ signicantly from subjects who
weighed .45 kg (P.0.05).
Postprandial glucose excursions
Figure 1 presents the mean postprandial
glucose excursions by meal type at each
time point (30-min increments from 0 to
300 min). Differences in mean glucose
excursions between the test meals became
apparent from ~120 min after the meals,
with a sustained and attenuated additive
effect of the HF/HP meal. The mean glu-
cose excursions after the LF/HP meal were
signicantly greater than the mean glu-
cose excursions after the LF/LP meal com-
mencing at 180 min (P=0.02)and
continuing to 300 min (P,0.01) (Table
3). The mean glucose excursions after the
HF/LP meal were signicantly higher than
the glucose excursions after the LF/LP meal
at 210 min (P= 0.01)and continuing to 300
min (P,0.01).
The HF/HP meal resulted in signi-
cantly higher glucose excursions from
180 min to 300 min compared with all
other meals (P,0.04) (Fig. 1). Com-
pared with the LF/LP meal, mean glucose
excursions were signicantly greater from
150 min after the HF/HP meal (P= 0.004)
(Table 3). At 300 min, the mean glucose
excursion for the HF/HP meal was 5.4
mmol/L higher than for the LF/LP meal
(P,0.001).
The HF/LP meal reduced the glucose
excursion within the rst 6090 min after
the meal compared with all other meals
(Table 3). The mean excursion at 60 min
after the HF/LP meal was signicantly
lower than the excursion for the LF/LP
meal (P= 0.009). This effect was only
seen for the LP/HF meal.
Beyond 120 min, the glycemic pro-
les after the HF/LP meal were similar to
the proles after the LF/HP meal (Fig. 1).
There was no statistically signicant inter-
action between the effects of the fat and
protein on glucose excursions at all time
points (P.0.05), which is consistent
with their effects being additive. The ef-
fects of protein and fat on glucose excur-
sions were additive, as indicated by the
lack of interaction of the two effects and
as seen in Fig. 1. For example, at 180 min
the mean glucose excursion for the HF/
HP meal (4.2 mmol/L [95% CI 2.55.9])
was equivalent to the combined excur-
sions of the LF/HP meal (2.4 mmol/L
[1.13.7]) and the HF/LP meal (1.8
mmol/L [0.53.0]).
Peak glucose excursion and time
to peak glucose
There was a signicant difference in peak
glucose excursions between meal types
(P= 0.049), with the highest value
recorded after the HF/HP meal. The
mean peak glucose excursions from
baseline for the LF/LP, LF/HP, HF/LP, and
Table 2dClinical characteristics of participants
Demographics
Center
Perth, Australia 23
Newcastle, Australia 10
Sex 16
Male
Female 17
Insulin pump therapy 27
Multiple daily injection therapy 6
Age (years) 12.2 62.5
Duration of diabetes (years) 4.9 63.2
BMI zscore 0.6 60.8
HbA
1c
, % (mmol/mol) 7.2 60.8 (55 68.7)
Insulin-to-carbohydrate ratio (units/g) 1:11.0 64.8
Data are presented as means 6SD.
care.diabetesjournals.org DIABETES CARE ,VOLUME 36, DECEMBER 2013 3899
Smart and Associates
©
HF/HP meals, respectively, were 4.7
mmol/L (95% CI 3.65.8), 4.4 mmol/L
(3.55.3), 4.3 mmol/L (3.1 to 5.4), and
5.9 mmol/L (4.67.3).
There was also a statistically signi-
cant difference in the time to mean peak
glucose excursion between meal types (P
,0.001), with the longest time being ob-
served after the HF/HP meal. The mean
time to peak glucose excursion for the LF/
LP, LF/HP, HF/LP, and HF/HP meals, re-
spectively, were 79 min (95% CI 6889),
96 min (74119) min, 126 min (97154)
min, and 143 min (112 to 174).
Hypoglycemic events
Twenty-nine symptomatic hypoglycemic
events occurred in the 5-h postprandial
period during the study. Fourteen oc-
curred in the LF/LP group, 10 in the HF/
LP group, 4 in the LF/HP group, and 1 in
the HF/HP group. There were no episodes
of severe hypoglycemia. The number of
hypoglycemic events differed signi-
cantly between the four meal types (P=
0.003). There was a statistically signi-
cant reduction in the odds of a hypogly-
cemic event when children consumed
the HP meals (odds ratio 0.16 [95% CI
0.060.41]; P,0.001) but not when
they consumed the HF meals (odds ratio
0.50 [0.221.09]; P= 0.08).
CONCLUSIONSdThis study has
demonstrated an effect of dietary protein
independent of fat on postprandial glyce-
mia in children with T1D. Importantly,
the glycemic rise after protein was shown
in meals of both HF and LF contents, with
identical carbohydrate quantities. In ad-
dition, when a meal containing high levels
of both protein and fat was eaten, the
impact of protein and fat was additive and
caused signicantly higher glucose excur-
sions between 3 and 5 h postprandially
compared with meals of only HF or HP
contents.
An important nding of this study
was that there were signicantly higher
glycemic excursions for the HP and HF
mealscomparedwiththeLP/LFmeal
from ~180 to 300 min postprandially.
This late effect was increased and sus-
tained when the HF and HP loads were
combined. As expected, the HF meal
initially reduced the glycemic excursion
for up to 90 min after the meal. This is
most likely due to the effect of fat in
delaying gastric emptying (10,11) and is
consistent with studies in both adoles-
cents with T1D (10) and patients with
type 2 diabetes (12). However in our
study, the addition of protein to the HF
meal prevented this, suggesting that
proteinmayhaveaprotectiveeffectin
the development of early postprandial
hypoglycemia.
The cause of the late sustained hy-
perglycemia noted when meals high in
protein and fat are eaten has been postu-
lated but is currently unknown. Protein
may lead to delayed hyperglycemia by
Figure 1dMean postprandial glucose excursions from 0 to 300 min for 33 subjects after test
meals of LF/LP (C), LF/HP (), HF/LP (), and HF/HP (,) content. Carbohydrate amount
was the same in all meals. There were signicant differences in glucose excursions between meal
types from 150 to 300 min (P,0.03). Error bars represent 95% CIs.
Table 3dMean postprandial glucose excursions by meal type at 30-min intervals to 300 min
Minutes
after meal
Mean postprandial glucose excursions (mmol/L)
LF/LP LF/HP HF/LP HF/HP
30 1.6 (1.12.1) 1.8 (1.42.2) 0.9 (0.51.3)* 1.6 (1.12.1)
60 3.6 (2.74.4) 3.4 (2.74.1) 2.2 (1.53.0)* 3.5 (2.34.6)
90 4.0 (2.95.1) 3.5 (2.64.4) 3.4 (2.34.5) 4.0 (2.65.4)
120 3.3 (2.04.5) 3.2 (2.14.2) 3.1 (1.94.4) 4.1 (2.65.6)
150 1.8 (0.63.0) 3.0 (1.74.3) 2.4 (1.13.6) 4.2 (2.55.9)*
180 0.5 (20.8 to 1.8) 2.4 (1.13.7)* 1.8 (0.53.0) 4.2 (2.55.9)*
210 20.5 (21.9 to 0.8) 1.9 (0.53.1)* 1.8 (0.33.2)* 3.9 (2.05.7)*
240 21.4 (22.8 to 20.1) 1.2 (20.1 to 2.5)* 1.5 (20.2 to 3.1)* 4.1 (2.35.8)*
270 22.2 (23.6 to 20.8) 0.6 (20.8 to 1.9)* 0.7 (21.0 to 2.4)* 2.7 (0.94.5)*
300 22.9 (24.5 to 21.3) 20.3 (21.8 to 1.2)* 0.6 (21.6 to 2.7)* 2.5 (0.54.5)*
Data are presented as means (95% CI). *Statistically different compared with glucose excursion for the LF/LP meal at that time point (P#0.05).
3900 DIABETES CARE,VOLUME 36, DE CEMBER 2013 care.diabetesjournals.org
Protein and fat impact postprandial glycemia
©
gluconeogenesis and increased glucagon
secretion (13). Proposed mechanisms by
which dietary fat and free fatty acids con-
tribute to hyperglycemia are by impairing
insulin sensitivity and enhancement of
hepatic glucose production, along with
delayed gastric emptying, which causes
an increase in the peak time and ampli-
tude of the glucose response (11). Fur-
ther studies are required to fully
elucidate the pathways of action.
The results of this study have direct
clinical translation. The protein, fat, and
carbohydrate contents in this study were
based on real meals commonly consumed
by children and adolescents. For such
meals, patients may be advised that sig-
nicant hyperglycemia is likely to occur
between 3 and 5 h after the meal, partic-
ularly accentuated and prolonged for the
HF/HP meal. The ndings of this study
suggest the need for both prolonging
insulin delivery by the use of a different
wave form, such as a dual-wave bolus in
those on pump therapy and that addi-
tional insulin is required to match the
delayed hyperglycemia. Future studies
are needed to determine an alternative
insulin dosing algorithm to separately
account for the fat and protein in HF/HP
meals.
Typically, insulin bolus dosing has
been determined using the insulin-to-
carbohydrate ratio. Our ndings support
recent evidence that dietary fat increases
insulin requirements (7), but suggest that
the additional insulin should be given by
an extended insulin bolus or as a split bo-
lus in order to prevent early hypoglyce-
mia. This study also adds new data
pointing to the need for additional insulin
for HP meals independent of the fat con-
tent. A feature of insulin pump therapy
that is potentially advantageous is the
ability to vary the delivery of a bolus of
insulin over time by use of a dual-wave or
square-wave bolus. A dual-wave bolus
has already been shown to limit glycemic
excursions in pizza studies (14,15). The
question of the optimal timing and distri-
bution of the bolus in combined HF and
HP meals, however, requires more inves-
tigation. Some centers have recently re-
ported their experiences in pump
patients of calculating fat and protein
units and using these to determine insulin
bolus dosing for the mixed meals (6,16).
These studies provide some data using a
normal-wave bolus given for carbohy-
drate and also a square-wave bolus with
supplementary insulin for the fat and pro-
tein content. While reduced postprandial
hyperglycemia has been noted, the rate of
hypoglycemia using these calculations
has been unacceptably high (3335%)
(6,16). There has also been a lack of stan-
dardization of bolus types between the
groups (16), which makes it difcult to
compare the effect of additional insulin
as opposed to the method of insulin de-
livery. Clearly, further studies are needed
to rene and quantify the extra insulin
that is required for HF or HP meals and
to determine algorithms for the best dose
and rate of insulin delivery over time.
A limitation of the study was that we
did not examine the effect of protein and
fat beyond 5 h, although previous studies
have noted an effect of HF/HP meals after
this time period (14,15). During daylight
hours, food is typically eaten so frequently
that additional bolus doses of insulin
within a few hours of the meal may correct
the hyperglycemia. We therefore suggest
that the composition of the evening meal
is particularly important to consider in
mealtime insulin calculations, as in the
case of fasting overnight no additional in-
sulin is given and prolonged hyperglycemia
may result. Furthermore, our data from
this and previous studies (17,18) indicate
that postprandial testing may be more ap-
propriate at 3 h rather than 2 h after the
meal, as the glycemic excursion from even
those meals lower in fat and protein did not
return to baseline until this time.
In conclusion, this is the rst study to
demonstrate that the addition of protein
and fat to meals containing the same
carbohydrate amount results in pro-
longed postprandial hyperglycemia in
childrenusingIIT.Whentheprotein
and fat were consumed together, there
wasanadditiveeffectonpostprandial
glycemia. Furthermore, the protein ap-
peared to have a protective effect against
hypoglycemia. This study provides sup-
portive evidence that protein and fat
should both be considered in insulin
dosing.
AcknowledgmentsdA Telethon Foundation
Fellowship grant supported S.M.O.s contri-
bution to this study. A Hunter ChildrensRe-
search Foundation grant supported the
Newcastle study site.
This project was supported by a Pzer
Australia Paediatric Endocrine Care Research
grant. No other potential conicts of interest
relevant to this article were reported.
C.E.M.S. conceived, designed, and con-
ducted the study; recruited subjects; collected
data; and wrote th e manuscript. M.E. recruited
subjects, conducted the study, and collected
data. S.M.O. designed and conducted the
study, recruited subjects, collected data, and
wrote the manuscript. P.M. analyzed data and
contributed to the writing of the manuscript.
P.E.L. recruited subjects, conducted the study,
collected data, and contributed to the writing
of the manuscript. T.W.J., E.A.D., and B.R.K.
contributed to the discussion and reviewed
and edited the manuscript. B.R.K. is the
guarantor of this work and, as such, had full
access to all the data in the study and takes
responsibility for the integrity of the data and
the accuracy of the data analysis.
Parts of this study we re presented in abstract
form at the 73rd ScienticSessionsofthe
American Diabetes Association, Chicago, Illi-
nois, 2125 June 2013.
The authors thank Niru Paramalingam and
Adam Retterath, Princess Margaret Hospital,
and Virginia McRory, John Hunter Childrens
Hospital, for their support with the equipment
and preparation of the test meals.
References
1. Laurenzi A, Bolla AM, Panigoni G, et al.
Effects of carbohydrate counting on glu-
cose control and quality of life over 24
weeks in adult patients with type 1 di-
abetes on continuous subcutaneous in-
sulin infusion: a randomized, prospective
clinical trial (GIOCAR). Diabetes Care
2011;34:823827
2. DAFNE Study Group. Training in exible,
intensive insulin management to enable
dietary freedom in people with type 1
diabetes: dose adjustment for normal
eating (DAFNE) randomised controlled
trial. BMJ 2002;325:746749
3. Scavone G, Manto A, Pitocco D, et al. Ef-
fect of carbohydrate counting and medical
nutritional therapy on glycaemic control
in Type 1 diabetic subjects: a pilot study.
Diabet Med 2010;27:477479
4. Lowe J, Linjawi S, Mensch M, James K,
Attia J. Flexible eating and exible insulin
dosing in patient s with diabetes: Results of
an intensive self-management course. Di-
abetes Res Clin Pract 2008;80:439443
5. Pa
nkowska E, Szypowska A, Lipka M,
Szpota
nska M, BłazikM,GroeleL.Ap-
plication of novel dual wave meal bolus
and its impact on glycated hemoglobin
A1c level in children with type 1 diabetes.
Pediatr Diabetes 2009;10:298303
6. Kordonouri O, Hartmann R, Remus K,
Bläsig S, Sadeghian E, Danne T. Benetof
supplementary fat plus protein counting
as compared with conventional carbohy-
drate counting for insulin bolus calcula-
tion in children with pump therapy.
Pediatr Diabetes 2012;13:540544
7. Wolpert HA, Atakov-Castillo A, Smith SA,
Steil GM. Dietary fat acutely increases
glucose concentrations and insulin re-
quirements in patients with type 1 diabetes:
implications for carbohydrate-based bolus
dose calculation and intensive diabetes
care.diabetesjournals.org DIABETES CARE ,VOLUME 36, DECEMBER 2013 3901
Smart and Associates
©
management. Diabetes Care 2013;36:
810816
8. Øverby NC, Flaaten V, Veierød MB, et al.
Children and adolescents with type 1 di-
abetes eat a more atherosclerosis-prone
diet than healthy control subjects. Dia-
betologia 2007;50:307316
9. National Health and Medical Research
Council. Nutrient Reference Values for Aus-
tralia and New Zealand Executive Summary.
Canberra, Australia, Department of Health
and Ageing, 2005
10. Lodefalk MAJ, Aman J, Bang P. Effects of fat
supplementation on glycaemic response and
gastric emptying in adolescents with Type 1
diabetes. Diabet Med 2008;25:10301035
11. Wolever TMMY, Mullan YM. Sugars and
fat have different effects on postprandial
glucose responses in normal and type 1
diabetic subjects. Nutr Metab Cardiovasc
Dis 2011;21:719725
12. Gentilcore D, Chaikomin R, Jones KL, et al.
Effects of fat on gastric emptying of and the
glycemic, insulin, and incretin responses to a
carbohydrate meal in type 2 diabetes. J Clin
Endocrinol Metab 2006;91:20622067
13. Peters AL, Davidson MB. Protein and fat
effects on glucose responses and insulin
requirements in subjects with insulin-
dependent diabetes mellitus. Am J Clin
Nutr 1993;58:555560
14. Jones SM, Quarry JL, Caldwell-McMillan
M, Mauger DT, Gabbay RA. Optimal in-
sulin pump dosing and postprandial gly-
cemia following a pizza meal using the
continuous glucose montoring system.
Diabetes Technol Ther 2005;7:233240
15. Lee SW, Cao M, Sajid S, et al. The dual-
wave bolus feature in continuous sub-
cutaneous insulin infusion pumps controls
prolonged post-prandial hyperglycaemia
better than standard bolus in Type 1
diabetes. Diabetes Nutr Metab 2004;17:
211216
16. Pa
nkowska E, Blazik M, Groele L. Does
the fat-protein meal increase postprandial
glucose level in type 1 diabetes patients on
insulin pump: the conclusion of a ran-
domized study. Diabetes Technol Ther
2012;14:1622
17. SmartCE,RossK,EdgeJA,CollinsCE,
Colyvas K, King BR. Children and
adolescents on intensive insulin ther-
apy maintain postprandial glycaemic
control without precise carbohydrate
counting. Diabet Med 2009;26:279
285
18. Smart CE, King BR, McElduff P, Collins
CE. In children using intensive insulin
therapy, a 20-g variation in carbohydrate
amount signicantly impacts on post-
prandial glycaemia. Diabet Med 2012;29:
e21e24
3902 DIABETES CARE,VOLUME 36, DE CEMBER 2013 care.diabetesjournals.org
Protein and fat impact postprandial glycemia
©
... 5,6 While there is growing evidence that all macronutrients impact postprandial glycemia, traditional approaches to insulin dosing, whether by injection, open-loop pump therapy, or hybrid closed-loop systems, utilize carbohydrate quantification and do not take into account the impact of fat and protein intake on glycemic excursions. [7][8][9][10] Consequently, it may be helpful to consider approaches for insulin dosing that accounts for high-fat or high-protein meals or snacks in real-life scenarios to refine decision support systems aimed at improving glycemic control. ...
... Research on the role of macronutrients in postprandial glycemia has grown in the last decade, especially with regard to fat and protein intake. 7,8,10 Test meals have shown that both fat and protein can lower postprandial glucose and reduce glycemic variability in youth with type 1 diabetes. 16 In our study, however, higher fat and protein intake were associated with higher A1c, suggesting that fat and protein intake can additionally impact overall glycemic control although it may blunt the postprandial rise in glucose. ...
... There have been a number of studies providing insulin dose recommendations to account for the protein and fat in meals. [7][8][9][10]17,18 While carbohydrate intake remains the focus of nutrition education and insulin dosing recommendations to achieve target glycemic control, there is likely need to consider the impact of protein and fat intake on basal and bolus insulin dose calculations. Strategies such as dual or square wave bolusing have yielded improved glycemic excursions following fat-protein meals. ...
Article
Objective: Insulin bolus doses derive from glucose levels and planned carbohydrate intake, although fat and protein impact glycemic excursions. We examined the impact of macronutrients and number of daily meals/snacks on glycemic outcomes in youth with type 1 diabetes. Methods: Youth (N = 136, ages 8-17) with type 1 diabetes completed 3-day food records, wore 3-day masked continuous glucose monitoring, and had A1c measurements every 3 months for 1 year. Diet data were analyzed using Nutrition Data System for Research. Longitudinal mixed models assessed effects of macronutrient intake and number of meals/snacks on glycemic outcomes. Results: At baseline, youth (48% male) had mean age of 12.8 ± 2.5 years and diabetes duration of 5.9 ± 3.1 years; 73% used insulin pumps. Baseline A1c was 8.1% ± 1.0%, percent time in range 70-180 mg/dL (%TIR) was 49% ± 17%, % time below range <70 mg/dL (%TBR) was 6% ± 8%, % time above range >180 mg/dL (%TAR) was 44% ± 20%, and glycemic variability as coefficient of variation (CV) was 41% ± 8%; macronutrient intake included 48% ± 5% carbohydrate, 36% ± 5% fat, and 16% ± 2% protein. Most youth (56%) reported 3-4 meals/snacks daily (range 1-9). Over 1 year, greater carbohydrate intake was associated with lower A1c (P = 0.0003), more %TBR (P = 0.0006), less %TAR (P = 0.002), and higher CV (P = 0.03). Greater fat intake was associated with higher A1c (P = 0.006), less %TBR (P = 0.002), and more %TAR (P = 0.005). Greater protein intake was associated with higher A1c (P = 0.01). More daily meals/snacks were associated with lower A1c (P = 0.001), higher %TIR (P = 0.0006), and less %TAR (P = 0.0001). Conclusions: Both fat and protein impact glycemic outcomes. Future automated insulin delivery systems should consider all macronutrients for timely insulin provision. The present research study derived from secondary analysis of the study registered under NCT00999375.
... Carbohydrate counting (CC) is one of the most effective strategies for promoting glycemic control in patients with T1DM, as carbohydrate is the macronutrient that most impacts the increase in blood glucose, since it is 100% converted into glucose; this process occurs between fifteen minutes and two hours after food intake [3,4]. However, counting fats and proteins can also be considered beneficial for glycemic and metabolic control, since some studies have shown that these macronutrients can also significantly affect the postprandial glycemic profile [5,6]. According to Paterson et al. [7], it has been shown that there are controversies related to the impact of fat and protein on postprandial glycemia, as the combination of meals composed of the three macronutrients resulted in a reduction in the early postprandial increase and the development of postprandial hyperglycemia in the late period [8]. ...
Article
Full-text available
Carbohydrate counting is one of the dietary strategies used for the management of type 1 diabetes (T1DM), and counting proteins and fats allows individuals to achieve better glycemic and metabolic control, reducing glycemic variability and long-term complications. The aim of this paper is to analyze the factors associated with adherence to the protein- and fat-counting strategy in adults with T1DM. This cross-sectional study was conducted from November 2021 to June 2022 through an online questionnaire. We applied Pearson’s Chi-square test with adjusted residual analysis and a binomial logistic regression test using SPSS software, version 24.0, considering p < 0.05 as indicative of statistical significance. There was an association between performing protein and lipid counting and having a higher education level, income exceeding three minimum wages, and having adequate glycated hemoglobin. Performing protein and lipid counting increased the chances of having adequate HbA1c by 4.3 times. Protein and lipid counting was a predictor of having adequate HbA1c. The results suggest that considering the practice of counting proteins and fats is important as a strategy to optimize glycemic control.
... These nutrients are known to exert a significant impact on glycemic control and can also influence the systemic inflammatory profile of the individual. 43 The interplay between these factors underscores their importance in the management of T1D and offers a plausible explanation for the enhanced performance of our predictive model when this nutritional information was integrated into the dataset. ...
Article
Full-text available
Gut microbiota has been implicated in various clinical conditions, yet the substantial heterogeneity in gut microbiota research results necessitates a more sophisticated approach than merely identifying statistically different microbial taxa between healthy and unhealthy individuals. Our study seeks to not only select microbial taxa but also explore their synergy with phenotypic host variables to develop novel predictive models for specific clinical conditions. Design: We assessed 50 healthy and 152 unhealthy individuals for phenotypic variables (PV) and gut microbiota (GM) composition by 16S rRNA gene sequencing. The entire modeling process was conducted in the R environment using the Random Forest algorithm. Model performance was assessed through ROC curve construction. Results: We evaluated 52 bacterial taxa and pre-selected PV (p < 0.05) for their contribution to the final models. Across all diseases, the models achieved their best performance when GM and PV data were integrated. Notably, the integrated predictive models demonstrated exceptional performance for rheumatoid arthritis (AUC = 88.03%), type 2 diabetes (AUC = 96.96%), systemic lupus erythematosus (AUC = 98.4%), and type 1 diabetes (AUC = 86.19%). Conclusion: Our findings underscore that the selection of bacterial taxa based solely on differences in relative abundance between groups is insufficient to serve as clinical markers. Machine learning techniques are essential for mitigating the considerable variability observed within gut microbiota. In our study, the use of microbial taxa alone exhibited limited predictive power for health outcomes, while the integration of phenotypic variables into predictive models substantially enhanced their predictive capabilities.
Article
Objective Going extended periods of time without eating increases risk for binge eating and is a primary target of leading interventions for binge‐spectrum eating disorders (B‐EDs). However, existing treatments for B‐EDs yield insufficient improvements in regular eating and subsequently, binge eating. These unsatisfactory clinical outcomes may result from limitations in assessment and promotion of regular eating in therapy. Detecting the absence of eating using passive sensing may improve clinical outcomes by facilitating more accurate monitoring of eating behaviours and powering just‐in‐time adaptive interventions. We developed an algorithm for detecting meal consumption (and extended periods without eating) using continuous glucose monitor (CGM) data and machine learning. Method Adults with B‐EDs ( N = 22) wore CGMs and reported eating episodes on self‐monitoring surveys for 2 weeks. Random forest models were run on CGM data to distinguish between eating and non‐eating episodes. Results The optimal model distinguished eating and non‐eating episodes with high accuracy (0.82), sensitivity (0.71), and specificity (0.94). Conclusions These findings suggest that meal consumption and extended periods without eating can be detected from CGM data with high accuracy among individuals with B‐EDs, which may improve clinical efforts to target dietary restriction and improve the field's understanding of its antecedents and consequences.
Article
Postprandial glucose control can be challenging for individuals with type 1 diabetes, and this can be attributed to many factors, including suboptimal therapy parameters (carbohydrate ratios, correction factors, basal doses) because of physiological changes, meal macronutrients and engagement in postprandial physical activity. This narrative review aims to examine the current postprandial glucose‐management strategies tested in clinical trials, including adjusting therapy settings, bolusing for meal macronutrients, adjusting pre‐exercise and postexercise meal boluses for postprandial physical activity, and other therapeutic options, for individuals on open‐loop and closed‐loop therapies. Then we discuss their challenges and future avenues. Despite advancements in insulin delivery devices such as closed‐loop systems and decision‐support systems, many individuals with type 1 diabetes still struggle to manage their glucose levels. The main challenge is the lack of personalized recommendations, causing suboptimal postprandial glucose control. We suggest that postprandial glucose control can be improved by (i) providing personalized recommendations for meal macronutrients and postprandial activity; (ii) including behavioural recommendations; (iii) using other personalized therapeutic approaches (e.g. glucagon‐like peptide‐1 receptor agonists, sodium‐glucose co‐transporter inhibitors, amylin analogues, inhaled insulin) in addition to insulin therapy; and (iv) integrating an interpretability report to explain to individuals about changes in treatment therapy and behavioural recommendations. In addition, we suggest a future avenue to implement precision recommendations for individuals with type 1 diabetes utilizing the potential of deep reinforcement learning and foundation models (such as GPT and BERT), employing different modalities of data including diabetes‐related and external background factors (i.e. behavioural, environmental, biological and abnormal events).
Article
Aim Secondary analyses were conducted from a randomized trial of an adaptive behavioural intervention to assess the relationship between protein intake (g and g/kg) consumed within 4 h before moderate‐to‐vigorous physical activity (MVPA) bouts and glycaemia during and following MVPA bouts among adolescents with type 1 diabetes (T1D). Materials and Methods Adolescents (n = 112) with T1D, 14.5 (13.8, 15.7) years of age and 36.6% overweight/obese, provided measures of glycaemia using continuous glucose monitoring [percentage of time above range (>180 mg/dl), time in range (70‐180 mg/dl), time below range (TBR; <70 mg/dl)], self‐reported physical activity (previous day physical activity recalls), and 24 h dietary recall data at baseline and 6 months post‐intervention. Mixed effects regression models adjusted for design (randomization assignment, study site), demographic, clinical, anthropometric, dietary, physical activity and timing covariates estimated the association between pre‐exercise protein intake on percentage of time above range, time in range and TBR during and following MVPA. Results Pre‐exercise protein intakes of 10‐19.9 g and >20 g were associated with an absolute reduction of −4.41% ( p = .04) and −4.83% ( p = .02) TBR during physical activity compared with those who did not consume protein before MVPA. Similarly, relative protein intakes of 0.125‐0.249 g/kg and ≥0.25 g/kg were associated with −5.38% ( p = .01) and −4.32% ( p = .03) absolute reductions in TBR during physical activity. We did not observe a significant association between protein intake and measures of glycaemia following bouts of MVPA. Conclusions Among adolescents with T1D, a dose of ≥10 g or ≥0.125 g/kg of protein within 4 h before MVPA may promote reduced time in hypoglycaemia during, but not following, physical activity.
Article
Full-text available
OBJECTIVE Current guidelines for intensive treatment of type 1diabetes base the mealtime insulin bolus calculation exclusively on carbohydrate counting. There is strong evidence that free fatty acids impair insulin sensitivity. We hypothesized that patients with type 1 diabetes would require more insulin coverage for higher-fat meals than lower-fat meals with identical carbohydrate content.RESEARCH DESIGN AND METHODS We used a crossover design comparing two 18-h periods of closed-loop glucose control after high-fat (HF) dinner compared with low-fat (LF) dinner. Each dinner had identical carbohydrate and protein content, but different fat content (60 vs. 10 g).RESULTSSeven patients with type 1 diabetes (age, 55 ± 12 years; A1C 7.2 ± 0.8%) successfully completed the protocol. HF dinner required more insulin than LF dinner (12.6 ± 1.9 units vs. 9.0 ± 1.3 units; P = 0.01) and, despite the additional insulin, caused more hyperglycemia (area under the curve >120 mg/dL = 16,967 ± 2,778 vs. 8,350 ± 1,907 mg/dL⋅min; P < 0001). Carbohydrate-to-insulin ratio for HF dinner was significantly lower (9 ± 2 vs. 13 ± 3 g/unit; P = 0.01). There were marked interindividual differences in the effect of dietary fat on insulin requirements (percent increase significantly correlated with daily insulin requirement; R(2) = 0.64; P = 0.03).CONCLUSION This evidence that dietary fat increases glucose levels and insulin requirements highlights the limitations of the current carbohydrate-based approach to bolus dose calculation. These findings point to the need for alternative insulin dosing algorithms for higher-fat meals and suggest that dietary fat intake is an important nutritional consideration for glycemic control in individuals with type 1 diabetes.
Article
Full-text available
An insulin pump is an advanced technology offering new options of bolus - normal (N), dual wave (D-W) or square wave (S-W) bolus to deliver mealtime insulin. To assess the impact of D-W/S-W boluses on metabolic control (glycated haemoglobin A1c, HbA1c) and to estimate the paediatric patients compliance with implementation of this system in daily practice. The cross-sectional study included 499 records of patients aged 0-18 yr. Data from the insulin pump memory provided information on the number of D-W/S-W boluses during a 2-wk period, the insulin requirement (U/kg/d) and the percentage of basal insulin. The HbA1c value (%) and the patient's weight were determined during medical examinations. Mealtime dose of insulin in D-W/S-W bolus was calculated based on the amount of carbohydrate and fat/protein products. The number of applied D-W/S-W boluses was 16.6 +/- 0.77/14 d (ranged 0-95), while 18.8% of patients did not program D-W/S-W boluses. The lowest HbA1c value was found in the group using two and/or more D-W/S-W boluses per day (p = 0.001) compared with the group administrating less than one D-W/S-W bolus/d. Patients with HbA1c level <7.5% had a statistically higher relevant number of D-W/S-W boluses, 19.55 (95% CI: 17.44-21.65) vs. 12.42 (95% CI: 10.22-14.61) (p < 0.001), while there was no correlation between the number of boluses and HbA1c in patients in the remission phase (<0.5 IU/kg/d) (r = 0.012, p = 0.930). Patients using at least one D-W/S-W bolus per day achieved a recommended level of HbA1c. Paediatric patients with type 1 diabetes mellitus were found to be able to apply D-W/S-W boluses in daily self-treatment process based on food counting.
Article
Full-text available
Our study examines the hypothesis that in addition to sugar starch-type diet, a fat-protein meal elevates postprandial glycemia as well, and it should be included in calculated prandial insulin dose accordingly. The goal was to determine the impact of the inclusion of fat-protein nutrients in the general algorithm for the mealtime insulin dose calculator on 6-h postprandial glycemia. Of 26 screened type 1 diabetes patients using an insulin pump, 24 were randomly assigned to an experimental Group A and to a control Group B. Group A received dual-wave insulin boluses for their pizza dinner, consisting of 45 g/180 kcal of carbohydrates and 400 kcal from fat-protein where the insulin dose was calculated using the following algorithm: n Carbohydrate Units×ICR+n Fat-Protein Units×ICR/6 h (standard+extended insulin boluses), where ICR represents the insulin-to-carbohydrate ratio. For the control Group B, the algorithm used was n Carbohydrate Units×ICR. The glucose, C-peptide, and glucagon concentrations were evaluated before the meal and at 30, 60, 120, 240, and 360 min postprandial. There were no statistically significant differences involving patients' metabolic control, C-peptide, glucagon secretion, or duration of diabetes between Group A and B. In Group A the significant glucose increment occurred at 120-360 min, with its maximum at 240 min: 60.2 versus -3.0 mg/dL (P=0.04), respectively. There were no significant differences in glucagon and C-peptide concentrations postprandial. A mixed meal effectively elevates postprandial glycemia after 4-6 h. Dual-wave insulin bolus, in which insulin is calculated for both the carbohydrates and fat proteins, is effective in controlling postprandial glycemia.
Article
Full-text available
Few studies have assessed the efficacy of carbohydrate counting in type 1 diabetes, and none have validated its efficacy in patients who are treated with continuous subcutaneous insulin infusion (CSII). The aim of our study was to test the effect of carbohydrate counting on glycemic control and quality of life in adult patients with type 1 diabetes who are receiving CSII. Sixty-one adult patients with type 1 diabetes treated with CSII were randomly assigned to either learning carbohydrate counting (intervention) or estimating pre-meal insulin dose in the usual empirical way (control). At baseline and 12 and 24 weeks, we measured HbA(1c), fasting plasma glucose, BMI, waist circumference, recorded daily insulin dose, and capillary glucose data, and administered the Diabetes-Specific Quality-of-Life Scale (DSQOLS) questionnaire. Intention-to-treat analysis showed improvement of the DSQOLS score related to diet restrictions (week 24 - baseline difference, P = 0.008) and reduction of BMI (P = 0.003) and waist circumference (P = 0.002) in the intervention group compared with control subjects. No changes in HbA(1c), fasting plasma glucose, daily insulin dose, and hypoglycemic episodes (<2.8 mmol/L) were observed. Per-protocol analysis, including only patients who continuously used carbohydrate counting and CSII during the study, confirmed improvement of the DSQOLS score and reduction of BMI and waist circumference, and showed a significant reduction of HbA(1c) (-0.35% vs. control subjects, P = 0.05). Among adult patients with type 1 diabetes treated with CSII, carbohydrate counting is safe and improves quality of life, reduces BMI and waist circumference, and, in per-protocol analysis, reduces HbA(1c).
Article
To investigate carbohydrate (CARB) and supplementary fat/protein (CFP) counting using normal and dual-wave bolus in pump therapy of children and young people with type 1 diabetes (T1D). A randomized clinical trial was conducted in 42 patients (age 6–21 yr) with T1D for at least 1 yr (5.2 ± 3.1 yr, mean ± SD) and pump therapy for at least 3 months (3.3 ± 1.8 yr). Standardized test meals (pizza-salami; 50% carbohydrate, 34% fat, 16% protein; corresponding to 33% of age-adjusted daily energy requirement) were given at lunch time on four different days with normal and dual-wave bolus using CARB and CFP counting in a randomized sequence. Sensor-augmented pumps were used for continuous glucose monitoring of 6-h postprandial glucose profiles. Intra-individual comparisons of glucose parameters [area under the curve (AUC) mg/dL ×6 h; average glucose, AV mg/dL] were performed. Using CFP counting, 6-h postprandial glucose AUC (805 ± 261) and AV (137.8 ± 46.2) were significantly lower than AUC (926 ± 285) and AV (160.5 ± 51.9) by CARB counting (p < 0.001, each). CFP counting led to significantly lower postprandial glucose parameters independently from the kind of bolus (normal bolus: ΔAUC 169, p < 0.001; ΔAV 30.6, p < 0.001/dual-wave bolus: ΔAUC 73, p = 0.045, ΔAV 14.8, p = 0.033). Postprandial hypoglycemia episodes (<70 mg/dL) occurred more frequently in CFP than in CARB counting (35.7% vs. 9.5%, p < 0.001). No severe hypoglycemia was reported. In patients with long-term T1D, meal-related insulin dosing based on carbohydrate plus fat/protein counting reduces the postprandial glucose levels (ClinicalTrials.gov NCT01400659).
Article
To determine if an insulin dose calculated for a meal containing 60 g carbohydrate maintains postprandial glycaemic control for meals containing 40, 50, 70 or 80 g carbohydrate. Thirty-four young people (age range 8.5-17.7 years) using intensive insulin therapy consumed five test breakfasts with equivalent fat, protein and fibre contents but differing carbohydrate quantities (40, 50, 60, 70 and 80 g of carbohydrate). The preprandial insulin dose was the same for each meal, based on the subject's usual insulin:carbohydrate ratio for 60 g carbohydrate. Continuous glucose monitoring was used to monitor postprandial glucose over 180 min. The 40-g carbohydrate meal resulted in significantly more hypoglycaemia than the other meals (P = 0.003). There was a one in three chance of hypoglycaemia between 120 and 180 min if an insulin dose for 60 g carbohydrate was given for 40 g carbohydrate. The glucose levels of subjects on the 80-g meal were significantly higher than the 60- and 70-g carbohydrate meals at all time points between 150 and 180 min (P < 0.01). Subjects consuming the 80-g meal were more likely to have significant hyperglycaemia (blood glucose levels ≥ 12 mmol/l) compared with the other meals (P < 0.001). In patients using intensive insulin therapy, an individually calculated insulin dose for 60 g carbohydrate results in postprandial hypoglycaemia or hyperglycaemia for meals containing 40 and 80 g carbohydrate. To calculate mealtime insulin in order to maintain postprandial control, carbohydrate estimations should be within 10 g of the actual meal carbohydrate.
Article
We aimed to determine the effects on glycemic responses and potential risk of hypoglycaemia in type 1 diabetic subjects of replacing half the starch in a meal with sugars, and of adding fat to the low-sugar and high-sugar meals. We studied overnight fasted subjects with type 1 diabetes (n = 11) and age-, BMI- and ethnicity-matched controls (n = 11) using a 2 × 2 factorial design. The low-sugar/low-fat meal was 110 g white-bread. In the high-sugar/low-fat meal half the white-bread starch replaced by sugars (jam and orange juice). The high-fat meals consisted of the low-fat meals plus 20 g fat (margarine). The significance of the main effects of sugars and fat and the sugar × fat, group × sugar and group × fat interactions were determined by ANOVA. In control and diabetic subjects, respectively, high-sugar significantly reduced time to peak rise by 13% (P = 0.004) and 32% (P = 0.004; group × sugar: P = 0.01) and increased peak rise by 14% and 10% (ns). Adding fat increased time to peak rise by 17-19% in both groups (P = 0.003), reduced peak rise by 31% in normal (P < 0.001) but increased peak rise in diabetic subjects by 3% (ns) (group × fat: P = 0.022). Blood glucose nadir and occurrence of hypoglycaemia were similar among the 4 meals. In type 1 diabetes, insulin adjustment to avoid hypoglycemia may be useful for meals in which the proportion of carbohydrate absorbed as glucose is <0.75, however the precise level which increases hypoglycaemic risk requires further research. The results suggest that people with type 1 diabetes should not be advised to add fat to meals to reduce glycemic responses.
Article
The effect of a balanced, carbohydrate-counting diet on glycaemic control in Type 1 diabetic subjects is unclear. Our aim was to determine its effect in a small, pilot trial. We randomized 256 Type 1 diabetic subjects to a Nutritional Education Programme (group A) or not (group B). Weight, body mass index, glycated haemoglobin (HbA1c), lipid profile, urate, creatinine, microalbuminuria and daily insulin requirements were measured at baseline and at the end of the study (9 months). During the study, the number of hypoglycaemic events (blood glucose<3.9 mmol/l) was also measured. Compared with group B, group A showed: (i) a reduction in HbA1c (group A: 7.8+/-1.3-7.4+/-0.9%; group B: 7.5+/-0.8-7.5+/-1.1%; P<0.01); (ii) less hypoglycaemic events (4% vs. 7%; P<0.05); (iii) a reduction in dose of rapid insulin analogues (23.5+/-10.9 vs. 27.7+/-17.1 IU/24 h; P=0.03). No other between-group changes were observed. This study shows the importance of medical nutritional therapy on glycaemic control in Type 1 diabetic subjects.
Article
Objectives: To evaluate whether a course teaching flexible intensive insulin adjustment can improve both glycaemic control and quality of life in type 1 diabetes. Design: randomized design with participants either attending training immediately (immediate DAFNE) or acting as waiting list controls and attending "delayed DAFNE" training 6 months later. Setting: Secondary care diabetes clinics in three English health districts. Participants: 169 adults with type 1 diabetes and moderate or poor glycaemic control. Main outcome measures: Glycated haemoglobin (HbA 1c), severe hypoglycaemia, impact of diabetes on quality of life (ADDQoL). Results: At 6 months, HbA 1c was significantly better in immediate DAFNE patients (mean 8.4%) than in delayed DAFNE patients (9.4%) (t=6.1, P<0.0001). The impact of diabetes on dietry freedom was significantly improved in immediate DAFNE patients compared with delayed DAFNE patients (t= -5.4, P<0.0001), as was the impact of diabetes on overall quality of life (t = 2.9, P<0.01). General wellbeing and treatment satisfaction were also significantly improved, but severe hypoglycaemia, weight, and lipids remained unchanged. Improvements in "present quality of life" did not reach significance at 6 months but were significant by 1 year. Conclusion: Skills training promoting dietary freedom improved quality of life and glycaemic control in people with type 1 diabetes without worsening severe hypoglycaemia or cardiovascular risk. This approach has the potential to enable more people to adopt intensive insulin treatment and is worthy of further investigation.